Suchergebnisse - Zhuo, Jianyong

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases von Yang, Xinyu, Lu, Di, Zhuo, Jianyong, Lin, Zuyuan, Yang, Modan, Xu, Xiao

Volltext Volltext Volltext

The ongoing trends of patient‐derived xenograft models in oncology von Zhuo, Jianyong, Su, Renyi, Tan, Winyen, Lian, Zhengxing, Lu, Di, Xu, Xiao

Volltext Volltext Volltext

Laparoscopic management of enterohepatic migrated fish bone mimicking liver neoplasm: A case report and literature review von Chen, Jun, Wang, Chao, Zhuo, Jianyong, Wen, Xue, Ling, Qi, Liu, Zhikun, Guo, Haijun, Xu, Xiao, Zheng, Shusen

Volltext Volltext Volltext

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma von Zhang, Xuanyu, Zhuang, Runzhou, Ye, Qianwei, Zhuo, Jianyong, Chen, Kangchen, Lu, Di, Wei, Xuyong, Xie, Haiyang, Xu, Xiao, Zheng, Shusen

Volltext Volltext Volltext

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1 von Ling, Sunbin, Xie, Haiyang, Yang, Fan, Shan, Qiaonan, Dai, Haojiang, Zhuo, Jianyong, Wei, Xuyong, Song, Penghong, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Volltext Volltext Volltext

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma von Wang, Jianguo, Zhuo, Jianyong, Tao, Yaoye, Xu, Shengjun, Chen, Zun, Yang, Fan, Ke, Qinghong, Xie, Haiyang, Zheng, Shusen, Wang, Hangxiang, Xu, Xiao

Volltext Volltext Volltext

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts von Zhuo, Jianyong, Lu, Di, Wang, Jianguo, Lian, Zhengxing, Zhang, Jiali, Li, Huihui, Cen, Beini, Wei, Xuyong, Wei, Qiang, Xie, Haiyang, Xu, Xiao

Volltext Volltext Volltext

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma von Zhuang, Runzhou, Lu, Di, Zhuo, Jianyong, Zhang, Xuanyu, Wang, Kun, Wei, Xuyong, Wei, Qiang, Wang, Wei, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Volltext Volltext Volltext

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma von Lu, Di, Yang, Fan, Zhuo, Jianyong, Yang, Modan, Lin, Zuyuan, Jin, Pingbo, Cai, Xuechun, Cen, Beini, Wang, Jianguo, Wei, Xuyong, Zheng, Shusen, Xu, Xiao

Volltext Volltext Volltext

A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study von Shen, Xiaoyong, Yang, Fan, Yang, Pengfei, Yang, Modan, Xu, Lei, Zhuo, Jianyong, Wang, Jianguo, Lu, Di, Liu, Zhikun, Zheng, Shu-sen, Niu, Tianye, Xu, Xiao

Volltext Volltext Volltext

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation von Yang, Xinyu, Lu, Di, Wang, Rui, Lian, Zhengxing, Lin, Zuyuan, Zhuo, Jianyong, Chen, Hao, Yang, Modan, Tan, Winyen, Yang, Mengfan, Wei, Xuyong, Wei, Qiang, Zheng, Shusen, Xu, Xiao

Volltext Volltext Volltext

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy von Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Volltext Volltext Volltext

Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021) von Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Volltext Volltext

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib von Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao

Volltext Volltext Volltext